Literature DB >> 22118895

Discovery of curcumin, a component of golden spice, and its miraculous biological activities.

Subash C Gupta1, Sridevi Patchva, Wonil Koh, Bharat B Aggarwal.   

Abstract

1. Curcumin is the active ingredient of the dietary spice turmeric and has been consumed for medicinal purposes for thousands of years. Modern science has shown that curcumin modulates various signalling molecules, including inflammatory molecules, transcription factors, enzymes, protein kinases, protein reductases, carrier proteins, cell survival proteins, drug resistance proteins, adhesion molecules, growth factors, receptors, cell cycle regulatory proteins, chemokines, DNA, RNA and metal ions. 2. Because of this polyphenol's potential to modulate multiple signalling molecules, it has been reported to possess pleiotropic activities. First demonstrated to have antibacterial activity in 1949, curcumin has since been shown to have anti-inflammatory, anti-oxidant, pro-apoptotic, chemopreventive, chemotherapeutic, antiproliferative, wound healing, antinociceptive, antiparasitic and antimalarial properties as well. Animal studies have suggested that curcumin may be active against a wide range of human diseases, including diabetes, obesity, neurological and psychiatric disorders and cancer, as well as chronic illnesses affecting the eyes, lungs, liver, kidneys and gastrointestinal and cardiovascular systems. 3. Although many clinical trials evaluating the safety and efficacy of curcumin against human ailments have already been completed, others are still ongoing. Moreover, curcumin is used as a supplement in several countries, including India, Japan, the US, Thailand, China, Korea, Turkey, South Africa, Nepal and Pakistan. Although inexpensive, apparently well tolerated and potentially active, curcumin has not been approved for the treatment of any human disease. 4. In the present article, we discuss the discovery and key biological activities of curcumin, with a particular emphasis on its activities at the molecular and cellular levels, as well as in animals and humans.
© 2011 The Authors. Clinical and Experimental Pharmacology and Physiology © 2011 Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22118895      PMCID: PMC3288651          DOI: 10.1111/j.1440-1681.2011.05648.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  183 in total

1.  Inhibition of pancreatic and lung adenocarcinoma cell survival by curcumin is associated with increased apoptosis, down-regulation of COX-2 and EGFR and inhibition of Erk1/2 activity.

Authors:  Shahar Lev-Ari; Alex Starr; Akiva Vexler; Vicki Karaush; Vered Loew; Joel Greif; Eyal Fenig; Dan Aderka; Rami Ben-Yosef
Journal:  Anticancer Res       Date:  2006 Nov-Dec       Impact factor: 2.480

2.  Protective single/combined treatment with betel leaf and turmeric against methyl (acetoxymethyl) nitrosamine-induced hamster oral carcinogenesis.

Authors:  M A Azuine; S V Bhide
Journal:  Int J Cancer       Date:  1992-05-28       Impact factor: 7.396

3.  Inhibition of NFkappaB activation with curcumin attenuates plasma inflammatory cytokines surge and cardiomyocytic apoptosis following cardiac ischemia/reperfusion.

Authors:  Chi-Hsiao Yeh; Tzu-Ping Chen; Yi-Cheng Wu; Yu-Min Lin; Pyng Jing Lin
Journal:  J Surg Res       Date:  2005-05-01       Impact factor: 2.192

4.  Reduction of periductal fibrosis in liver fluke-infected hamsters after long-term curcumin treatment.

Authors:  Somchai Pinlaor; Suksanti Prakobwong; Yusuke Hiraku; Porntip Pinlaor; Umawadee Laothong; Puangrat Yongvanit
Journal:  Eur J Pharmacol       Date:  2010-04-24       Impact factor: 4.432

5.  The effect of curcumin on corneal neovascularization in rabbit eyes.

Authors:  Jung Sub Kim; Jun Sub Choi; Sung Kun Chung
Journal:  Curr Eye Res       Date:  2010-04       Impact factor: 2.424

6.  Curcumin prevents intravesical tumor implantation of the MBT-2 tumor cell line in C3H mice.

Authors:  P Sindhwani; J A Hampton; M M Baig; R Keck; S H Selman
Journal:  J Urol       Date:  2001-10       Impact factor: 7.450

7.  Validated LC/MS/MS assay for curcumin and tetrahydrocurcumin in rat plasma and application to pharmacokinetic study of phospholipid complex of curcumin.

Authors:  Anchang Liu; Hongxiang Lou; Lixia Zhao; Peihong Fan
Journal:  J Pharm Biomed Anal       Date:  2005-11-28       Impact factor: 3.935

8.  Cytotoxic effects of curcumin on osteosarcoma cell lines.

Authors:  Denise K Walters; Roman Muff; Bettina Langsam; Walter Born; Bruno Fuchs
Journal:  Invest New Drugs       Date:  2007-12-11       Impact factor: 3.850

Review 9.  Curcumin as "Curecumin": from kitchen to clinic.

Authors:  Ajay Goel; Ajaikumar B Kunnumakkara; Bharat B Aggarwal
Journal:  Biochem Pharmacol       Date:  2007-08-19       Impact factor: 5.858

10.  Curcumin acts as anti-tumorigenic and hormone-suppressive agent in murine and human pituitary tumour cells in vitro and in vivo.

Authors:  C Schaaf; B Shan; M Buchfelder; M Losa; J Kreutzer; W Rachinger; G K Stalla; T Schilling; E Arzt; M J Perone; U Renner
Journal:  Endocr Relat Cancer       Date:  2009-09-02       Impact factor: 5.678

View more
  183 in total

1.  Curcumin protects dopaminergic neurons against inflammation-mediated damage and improves motor dysfunction induced by single intranigral lipopolysaccharide injection.

Authors:  Neha Sharma; Sheetal Sharma; Bimla Nehru
Journal:  Inflammopharmacology       Date:  2017-04-13       Impact factor: 4.473

2.  Curcumin induces G2/M arrest, apoptosis, NF-κB inhibition, and expression of differentiation genes in thyroid carcinoma cells.

Authors:  Suzan Schwertheim; Frederik Wein; Klaus Lennartz; Karl Worm; Kurt Werner Schmid; Sien-Yi Sheu-Grabellus
Journal:  J Cancer Res Clin Oncol       Date:  2017-03-06       Impact factor: 4.553

3.  Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st century.

Authors:  Wing-Hin Lee; Ching-Yee Loo; Mary Bebawy; Frederick Luk; Rebecca S Mason; Ramin Rohanizadeh
Journal:  Curr Neuropharmacol       Date:  2013-07       Impact factor: 7.363

Review 4.  Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases.

Authors:  Ajaikumar B Kunnumakkara; Devivasha Bordoloi; Ganesan Padmavathi; Javadi Monisha; Nand Kishor Roy; Sahdeo Prasad; Bharat B Aggarwal
Journal:  Br J Pharmacol       Date:  2016-10-21       Impact factor: 8.739

5.  Molecular docking analysis of curcumin analogues against kinase domain of ALK5.

Authors:  Shivananda Kandagalla; B S Sharath; Basavapattana Rudresh Bharath; Umme Hani; Hanumanthappa Manjunatha
Journal:  In Silico Pharmacol       Date:  2017-11-18

6.  Multiple effects of curcumin on promoting expression of the exon 7-containing SMN2 transcript.

Authors:  Dairong Feng; Yi Cheng; Yan Meng; Liping Zou; Shangzhi Huang; Jiuyong Xie
Journal:  Genes Nutr       Date:  2015-09-19       Impact factor: 5.523

7.  Fungal endophytes of turmeric (Curcuma longa L.) and their biocontrol potential against pathogens Pythium aphanidermatum and Rhizoctonia solani.

Authors:  G Vinayarani; H S Prakash
Journal:  World J Microbiol Biotechnol       Date:  2018-03-14       Impact factor: 3.312

Review 8.  Curcumin: A Review of Its Effects on Epilepsy.

Authors:  Fatemeh Forouzanfar; Muhammed Majeed; Tannaz Jamialahmadi; Amirhosein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

9.  Pro-growth role of the JMJD2C histone demethylase in HCT-116 colon cancer cells and identification of curcuminoids as JMJD2 inhibitors.

Authors:  Tae-Dong Kim; James R Fuchs; Eric Schwartz; Dalia Abdelhamid; Jonathan Etter; William L Berry; Chenglong Li; Michael A Ihnat; Pui-Kai Li; Ralf Janknecht
Journal:  Am J Transl Res       Date:  2014-05-15       Impact factor: 4.060

10.  Curcumin attenuates ischemia-like injury induced IL-1β elevation in brain microvascular endothelial cells via inhibiting MAPK pathways and nuclear factor-κB activation.

Authors:  Hua-Jiang Dong; Chong-Zhi Shang; Ding-Wei Peng; Jian Xu; Peng-Xiao Xu; Li Zhan; Peng Wang
Journal:  Neurol Sci       Date:  2014-03-21       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.